Article 11(1) of the EU AI Act, as amended by Regulation (EU) 2026/1744, lets SMEs provide Annex IV technical documentation in a simplified manner. This research note argues that simplification changes how information is presented, not the provider’s responsibility to maintain the evidence behind it. It proposes a minimum viable evidence architecture in which each technical-file claim is linked to an evidence source, version, date, accountable owner and human review state, with missing, stale or conflicting evidence blocking approval. A prototype for Annex IV Section 1, using a fictional provider and simulated evidence, demonstrates the pattern. It does not demonstrate legal compliance. Produced as part of the AIGN Junior AI Governance Fellowship (2026), mentored by Patrick Upmann. This revised version has not been re-reviewed by AIGN. The author is developing Emetis, the software used for the prototype, as a commercial product.
No takes yet. Share an insight, caveat, or question.
Larissa Engelbrecht (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: